High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma
To determine whether circulating tumor-reactive T cells are present in melanoma patients, unstimulated T cells from peripheral blood were tested for recognition of HLA-A2- or HLA-A1-matched melanoma cell lines using the ELISPOT assay. Eleven out of 19 patients with metastatic melanoma had a T-cell r...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 July 2000
|
| In: |
International journal of cancer
Year: 2000, Jahrgang: 87, Heft: 5, Pages: 659-664 |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.0.CO;2-7 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.0.CO;2-7 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/1097-0215%2820000901%2987%3A5%3C659%3A%3AAID-IJC7%3E3.0.CO%3B2-7 |
| Verfasserangaben: | Anne Letsch, Ulrich Keilholz, Dirk Schadendorf, Dirk Nagorsen, Alexander Schmittel, Eckhard Thiel and Carmen Scheibenbogen |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1588042928 | ||
| 003 | DE-627 | ||
| 005 | 20220815112054.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190226s2000 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.0.CO;2-7 |2 doi | |
| 035 | |a (DE-627)1588042928 | ||
| 035 | |a (DE-576)518042928 | ||
| 035 | |a (DE-599)BSZ518042928 | ||
| 035 | |a (OCoLC)1341040120 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Letsch, Anne |d 1974- |e VerfasserIn |0 (DE-588)1018975012 |0 (DE-627)684177706 |0 (DE-576)356714845 |4 aut | |
| 245 | 1 | 0 | |a High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma |c Anne Letsch, Ulrich Keilholz, Dirk Schadendorf, Dirk Nagorsen, Alexander Schmittel, Eckhard Thiel and Carmen Scheibenbogen |
| 264 | 1 | |c 28 July 2000 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.02.2019 | ||
| 520 | |a To determine whether circulating tumor-reactive T cells are present in melanoma patients, unstimulated T cells from peripheral blood were tested for recognition of HLA-A2- or HLA-A1-matched melanoma cell lines using the ELISPOT assay. Eleven out of 19 patients with metastatic melanoma had a T-cell response with up to 0.81%, 0.78%, 0.53%, 0.12%, 0.10%, 0.09%, 0.07%, 0.06%, 0.06%, 0.04%, and 0.04% of peripheral blood mononuclear cells (PBMC) secreting IFNγ upon exposure to various HLA-A2- or HLA-A1-matched melanoma cell lines. These T-cell responses were mediated by CD8+ T cells and could specifically be blocked by an anti-HLA-A2 antibody in HLA-A2-positive patients. Separation experiments performed in one melanoma patient showed tumor-reactive T cells in both the CD8+ effector T cell (CD45RA+/IFNγ+) as well as the CD8+ memory T-cell compartment (CD45RO+/IFNγ+). In 3 out of 5 patients, in whom autologous cell lines were available, similar frequencies of T cells in response to HLA-A1- or HLA-A2-matched allogeneic and autologous tumor cells were observed, while 2 patients had a T-cell response restricted to either the autologous or the allogeneic cell lines. These results give evidence for the presence of tumor-reactive CD8+ T cells in more than half of melanoma patients tested. Although some of these patients have clinical evidence for an immunological-mediated tumor control, several patients have growing tumors suggesting presence of escape mechanisms. | ||
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of cancer |d Bognor Regis : Wiley-Liss, 1966 |g 87(2000), 5, Seite 659-664 |h Online-Ressource |w (DE-627)269532781 |w (DE-600)1474822-8 |w (DE-576)079876129 |x 1097-0215 |7 nnas |a High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma |
| 773 | 1 | 8 | |g volume:87 |g year:2000 |g number:5 |g pages:659-664 |g extent:6 |a High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.0.CO;2-7 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/1097-0215%2820000901%2987%3A5%3C659%3A%3AAID-IJC7%3E3.0.CO%3B2-7 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190226 | ||
| 993 | |a Article | ||
| 994 | |a 2000 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1588042928 |e 3056663423 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 26.02.2019"],"recId":"1588042928","id":{"doi":["10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.0.CO;2-7"],"eki":["1588042928"]},"title":[{"title_sort":"High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma","title":"High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"28 July 2000","dateIssuedKey":"2000"}],"language":["eng"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2000","extent":"6","pages":"659-664","text":"87(2000), 5, Seite 659-664","volume":"87","issue":"5"},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Bognor Regis","dateIssuedKey":"1966","dateIssuedDisp":"1966-","publisher":"Wiley-Liss"}],"language":["eng"],"disp":"High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanomaInternational journal of cancer","note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"title":[{"subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer","title":"International journal of cancer"}],"id":{"eki":["269532781"],"doi":["10.1002/(ISSN)1097-0215"],"zdb":["1474822-8"],"issn":["1097-0215"]},"titleTranslated":[{"translated":"Journal international du cancer"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"International Union against Cancer"}],"titleAlt":[{"title":"Predictive oncology"}],"pubHistory":["1.1966 -"],"recId":"269532781"}],"physDesc":[{"extent":"6 S."}],"person":[{"given":"Anne","display":"Letsch, Anne","role":"aut","family":"Letsch","roleDisplay":"VerfasserIn"},{"given":"Dirk","role":"aut","display":"Schadendorf, Dirk","roleDisplay":"VerfasserIn","family":"Schadendorf"}],"name":{"displayForm":["Anne Letsch, Ulrich Keilholz, Dirk Schadendorf, Dirk Nagorsen, Alexander Schmittel, Eckhard Thiel and Carmen Scheibenbogen"]}} | ||
| SRT | |a LETSCHANNEHIGHFREQUE2820 | ||